We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VKTX icon
3576
Viking Therapeutics
VKTX
$3.94B
$28K ﹤0.01%
4,678
-2,148
-31% -$12.8K
WPM icon
3577
Wheaton Precious Metals
WPM
$61B
$28K ﹤0.01%
644
-1,650
-72% -$73.4K
YRD
3578
Yiren Digital
YRD
$108M
$28K ﹤0.01%
4,613
+4,413
+2,207% +$18.9K
BCOV
3579
DELISTED
Brightcove, Inc.
BCOV
$28K ﹤0.01%
1,960
-1,168
-37% -$18.8K
GATO
3580
DELISTED
Gatos Silver, Inc.
GATO
$28K ﹤0.01%
1,553
-2,114
-58% -$29.8K
GOEV
3581
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$28K ﹤0.01%
+6
New +$24.3K
SCU
3582
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$28K ﹤0.01%
1,126
+278
+33% +$6.69K
NYMX
3583
DELISTED
Nymox Pharmaceutical Corp
NYMX
$28K ﹤0.01%
17,431
+12,421
+248% +$23K
MNRL
3584
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$28K ﹤0.01%
1,336
-7,289
-85% -$132K
DBGI
3585
Digital Brands Group
DBGI
$9.08M
0
BPMP
3586
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
$28K ﹤0.01%
+1,911
New +$26.5K
AMRB
3587
DELISTED
American River Bankshares
AMRB
$28K ﹤0.01%
1,567
+1,534
+4,648% +$28.5K
LJPC
3588
DELISTED
La Jolla Pharmaceutical Company
LJPC
$28K ﹤0.01%
6,576
-1,436
-18% -$6.15K
ACI icon
3589
Albertsons Companies
ACI
$5.95B
$27K ﹤0.01%
1,359
-954
-41% -$18.5K
ALDX icon
3590
Aldeyra Therapeutics
ALDX
$91.1M
$27K ﹤0.01%
2,399
+873
+57% +$10.5K
ALNT icon
3591
Allient
ALNT
$1.94B
$27K ﹤0.01%
799
-359
-31% -$12.6K
AMR icon
3592
Alpha Metallurgical Resources
AMR
$1.95B
$27K ﹤0.01%
1,054
-8,138
-89% -$140K
ASPN icon
3593
Aspen Aerogels
ASPN
$510M
$27K ﹤0.01%
906
+88
+11% +$1.8K
BJRI icon
3594
BJ's Restaurants
BJRI
$1.44B
$27K ﹤0.01%
551
-2,247
-80% -$124K
DES icon
3595
WisdomTree US SmallCap Dividend Fund
DES
$2.21B
$27K ﹤0.01%
868
-59,664
-99% -$1.93M
TDAY
3596
USA Today Co
TDAY
$1B
$27K ﹤0.01%
4,750
-16,462
-78% -$84.1K
HONE
3597
DELISTED
HarborOne Bancorp
HONE
$27K ﹤0.01%
1,855
-2,901
-61% -$41.9K
HY icon
3598
Hyster-Yale Materials Handling
HY
$619M
$27K ﹤0.01%
365
-4,287
-92% -$333K
IEV icon
3599
iShares Europe ETF
IEV
$1.7B
$27K ﹤0.01%
+506
New +$27.1K
KELYA icon
3600
Kelly Services Class A
KELYA
$536M
$27K ﹤0.01%
1,118
-2,781
-71% -$68.7K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.